Published in Infect Immun on August 01, 2003
Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest (2004) 2.65
Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection. PLoS One (2009) 1.40
Vaccines for tuberculosis: novel concepts and recent progress. Clin Microbiol Rev (2005) 1.26
Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses. BMC Med Genomics (2008) 1.10
Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide Analyses. Front Immunol (2014) 0.98
Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals. Clin Vaccine Immunol (2011) 0.96
Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis. Clin Vaccine Immunol (2012) 0.87
Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology. F1000Res (2015) 0.79
Expression, purification and characterization of Mycobacterium tuberculosis RpfE protein. J Biomed Res (2012) 0.78
A Dormant Microbial Component in the Development of Preeclampsia. Front Med (Lausanne) (2016) 0.76
DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8(+) T cell responses. Clin Exp Vaccine Res (2014) 0.75
Identification of novel antigen candidates for a tuberculosis vaccine in the adult zebrafish (Danio rerio). PLoS One (2017) 0.75
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA (1994) 14.96
Tuberculosis: commentary on a reemergent killer. Science (1992) 14.51
Variation in protection by BCG: implications of and for heterologous immunity. Lancet (1995) 9.66
Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun (1995) 6.43
Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ (1994) 6.11
Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1995) 4.76
Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun (1994) 4.07
Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun (1992) 3.85
Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol (1995) 3.85
Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol (1998) 3.62
Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun (2002) 3.29
Therapy of tuberculosis in mice by DNA vaccination. Nature (1999) 2.99
A bacterial cytokine. Proc Natl Acad Sci U S A (1998) 2.88
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Is the development of a new tuberculosis vaccine possible? Nat Med (2000) 2.67
Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology (1996) 2.65
Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun (2001) 2.62
The host immune response to tuberculosis. Am J Respir Crit Care Med (1998) 2.35
The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins. J Bacteriol (1992) 2.33
A family of autocrine growth factors in Mycobacterium tuberculosis. Mol Microbiol (2002) 2.30
Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today (1999) 2.08
A mycobacterial extracytoplasmic function sigma factor involved in survival following stress. J Bacteriol (1997) 1.79
The rpf gene of Micrococcus luteus encodes an essential secreted growth factor. Mol Microbiol (2002) 1.56
Bacterial dormancy and culturability: the role of autocrine growth factors. Curr Opin Microbiol (2000) 1.49
Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease. J Immunol (2000) 1.46
The T cell response to secreted antigens of Mycobacterium tuberculosis. Immunobiology (1994) 1.44
Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect Immun (1997) 1.41
Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice. Infect Immun (2002) 1.29
An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis. Infect Immun (1998) 1.17
Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin Exp Immunol (2002) 1.14
Bacille Calmette-Guérin adenitis 30 years after immunization in a patient with AIDS. J Infect Dis (1989) 1.14
The importance of models of infection in the study of disease resistance. Trends Microbiol (2002) 1.02
Immunological requirements for a subunit vaccine against tuberculosis. Immunol Cell Biol (1997) 0.95
Deletion of the 19kDa antigen does not alter the protective efficacy of BCG. Tuber Lung Dis (2000) 0.87
An African perspective on the threat of tuberculosis and HIV/AIDS--can despair be turned to hope? Lancet (1999) 0.83
Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun (2005) 2.34
A family of autocrine growth factors in Mycobacterium tuberculosis. Mol Microbiol (2002) 2.30
Mutants of Mycobacterium tuberculosis lacking three of the five rpf-like genes are defective for growth in vivo and for resuscitation in vitro. Infect Immun (2005) 1.70
Muralytic activity of Micrococcus luteus Rpf and its relationship to physiological activity in promoting bacterial growth and resuscitation. Mol Microbiol (2006) 1.70
The rpf gene of Micrococcus luteus encodes an essential secreted growth factor. Mol Microbiol (2002) 1.56
Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice. Infect Immun (2003) 1.48
The OtsAB pathway is essential for trehalose biosynthesis in Mycobacterium tuberculosis. J Biol Chem (2005) 1.47
Formation of 'non-culturable' cells of Mycobacterium smegmatis in stationary phase in response to growth under suboptimal conditions and their Rpf-mediated resuscitation. Microbiology (2004) 1.47
Genome sequence of the Fleming strain of Micrococcus luteus, a simple free-living actinobacterium. J Bacteriol (2009) 1.25
Different innate ability of I/St and A/Sn mice to combat virulent Mycobacterium tuberculosis: phenotypes expressed in lung and extrapulmonary macrophages. Infect Immun (2003) 1.05
Separation by dielectrophoresis of dormant and nondormant bacterial cells of Mycobacterium smegmatis. Biomicrofluidics (2010) 0.99
Dormant ovoid cells of Mycobacterium tuberculosis are formed in response to gradual external acidification. Tuberculosis (Edinb) (2011) 0.98
Adoption of the transiently non-culturable state--a bacterial survival strategy? Adv Microb Physiol (2003) 0.96
Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis. J Infect Dis (2004) 0.95
B cells delay neutrophil migration toward the site of stimulus: tardiness critical for effective bacillus Calmette-Guérin vaccination against tuberculosis infection in mice. J Immunol (2009) 0.95
Dormant forms of Mycobacterium smegmatis with distinct morphology. Microbiology (2009) 0.94
Construction by dielectrophoresis of microbial aggregates for the study of bacterial cell dormancy. Biomicrofluidics (2010) 0.90
Finding of the low molecular weight inhibitors of resuscitation promoting factor enzymatic and resuscitation activity. PLoS One (2009) 0.89
Estimation of microbial viability using flow cytometry. Curr Protoc Cytom (2004) 0.87
H2 complex controls CD4/CD8 ratio, recurrent responsiveness to repeated stimulations, and resistance to activation-induced apoptosis during T cell response to mycobacterial antigens. J Leukoc Biol (2006) 0.85
Peptidoglycan fragments stimulate resuscitation of "non-culturable" mycobacteria. Antonie Van Leeuwenhoek (2012) 0.84
Constitutive differences in gene expression profiles parallel genetic patterns of susceptibility to tuberculosis in mice. Infect Immun (2006) 0.84
Toxin-antitoxin vapBC locus participates in formation of the dormant state in Mycobacterium smegmatis. FEMS Microbiol Lett (2014) 0.82
Structural changes and cellular localization of resuscitation-promoting factor in environmental isolates of Micrococcus luteus. Microb Ecol (2010) 0.81
Analysis of cellular phenotypes that mediate genetic resistance to tuberculosis using a radiation bone marrow chimera approach. Infect Immun (2005) 0.80
The role of histone-like protein, Hlp, in Mycobacterium smegmatis dormancy. FEMS Microbiol Lett (2010) 0.79
Capacity of lung stroma to educate dendritic cells inhibiting mycobacteria-specific T-cell response depends upon genetic susceptibility to tuberculosis. PLoS One (2013) 0.78
Mycobacterial dissemination and cellular responses after 1-lobe restricted tuberculosis infection of genetically susceptible and resistant mice. J Infect Dis (2004) 0.76
Drug testing in mouse models of tuberculosis and nontuberculous mycobacterial infections. Tuberculosis (Edinb) (2013) 0.76
Interleukin-11 drives early lung inflammation during Mycobacterium tuberculosis infection in genetically susceptible mice. PLoS One (2011) 0.76
Nonquaternary poly(diallylammonium) polymers with different amine structure and their biocidal effect on Mycobacterium tuberculosis and Mycobacterium smegmatis. Appl Microbiol Biotechnol (2015) 0.75